Hospital-acquired infection Diagnostics Market is Set to growth at CAGR of 7.5% from 2017 to 2023 | Abbott Laboratories, AdvanDX, Alere, AstraZeneca, Bayer Schering Pharma, Becton Dickinson & Company, Cepheid, Roche

Hospital-acquired infections are type of infections acquired during hospitalization and are commonly known as nosocomial infection. These infections can be acquired in hospital, nursing home, rehabilitation facility, outpatient clinic, or other clinical settings. They can be acquired from an infected patient, outside environment, or from a staff of that facility. The hospital-acquired infection diagnostics market is primarily driven by the growth in awareness among healthcare workers and proposed government initiatives by many governmental organizations. Further, in developing economies such as China, India, and Brazil, the cleanliness and hygiene is minimum. Hence, it results in more hospital-acquired infections, which further increases the demand for hospital-acquired infection diagnostics. However, the decline in hospital-acquired infections in the developed countries such as the U.S., Germany, and the UK impedes the market growth. The hospital-acquired infection diagnostics market was valued at $2,571 million in 2016, and is expected to reach at $4,311 million by 2023, registering a CAGR of 7.5% from 2017 to 2023.

The hospital-acquired infection diagnostics market is segmented based on product, test type, application, infection type, end user and region. Based on product this market is segmented into instrument and reagents and consumables. Based on test type, the market is classified into molecular diagnostics, urinalysis, and immunoassay. Based on application, the market is divided into disease testing and drug resistance testing. Further, based on infection type, it is classified into hospital acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal Infections, urinary tract infections (UTI), and others. Based on end user this market is segmented into hospital, clinics, ambulatory surgery centres (ASC) and others. By region, the market is analysed across North America, Europe, Asia-Pacific, and LAMEA.

Top Manufacturer Detail-

Abbott Laboratories, AdvanDX, Alere, AstraZeneca plc, Bayer Schering Pharma LLC, Becton Dickinson & Company, Cepheid Inc., Roche AG, Daiichi Sankyo, Hologic

Get Sample Copy of the Report: https://www.reportsweb.com/inquiry&RW00012659322/sample

Hospital-acquired infection Diagnostics Market 2023 segmentation by technology, applications, and five major geographical regions. This Report covers the Major Players’ data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size.

Table of Contents

1 Market Definition
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application

2 Global Market by Vendors
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors

3 Global Market by Type
3.1 Market Share
3.2 Introduction of End-Use by Different Products

4 Global Market by End-Use / Application
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs

5 Global Market by Regions
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa

8 Asia-Pacific Market
8.1 by Type
8.2 by End-Use / Application
8.3 by Regions

9 South America Market
9.1 by Type
9.2 by End-Use / Application
9.3 by Regions

10 Middle East & Africa Market
10.1 by Type
10.2 by End-Use / Application
10.3 by Regions

Place Direct Purchase order For Complete report @ https://www.reportsweb.com/buy&RW00012659322/buy/5370

Contact us:
Phone : +1-646-491-9876
E-Mail : sales@reportsweb.com

About us:

ReportsWeb is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers.

This release was published on openPR.